首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

市场调查报告书

商品编码

1542510

全球临床试验管理系统 (CTMS) 市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Clinical Trials Management System (CTMS) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球临床试验管理系统（CTMS）市场需求预计将从2023年的23.3亿美元达到2032年近84.2亿美元的市场规模，2024-2032年研究期间复合年增长率为15.32%。

临床试验是指评估新药、治疗方法、医疗器材或介入措施对人类参与者的功效、安全性和有效性的系统性研究。这些试验对于推进医学知识、开发新疗法以及在向公众提供治疗之前评估潜在风险和益处至关重要。这些研究遵循监管机构制定的严格协议和指南，以确保道德行为、参与者安全和可靠的资料收集。它们通常分阶段进行，从健康志愿者的小规模研究（第一阶段）到患者族群的大规模试验（第二阶段和第三阶段），最终进入监管审查和批准流程。

市场动态

慢性病的流行、人口老化以及对个人化医疗的需求推动了对透过临床试验评估的新疗法和治疗方案的需求。製药和生物技术公司、学术机构和政府机构投资临床研究，以满足未满足的医疗需求并改善患者的治疗效果。生物技术、基因组学和精准医学技术的进步加速了试验设计和执行，支持标靶治疗和生物标记驱动的方法。现实世界证据 (RWE) 与穿戴式装置和远端监控设备等数位健康技术的整合可提高试验效率、资料品质和患者参与度，促进分散试验模型和自适应试验设计。

此外，监管改革和简化临床试验流程和加快药物审批时间表的措施促进了临床研究的创新和投资。行业利益相关者、患者倡导团体和监管机构之间的合作可促进透明度、资料共享和以患者为中心的试验设计，从而提高招募率和保留率。为因应 COVID-19 大流行，采用虚拟和混合试验模型推动了试验实施和参与者访问方面的创新，为更灵活、更有弹性的临床试验生态系统铺平了道路。然而，试验成本高、招募和保留不同患者群体以及不同地区监管复杂性等挑战可能会阻碍临床试验市场的成长。

市场区隔

临床试验管理系统 (CTMS) 市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按解决方案类型

企业
地点

按组件

软体
服务

按交付方式

网路和云端
内部部署

按最终用户

製药和生物技术公司
医疗器材公司
CRO 及其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲临床试验管理系统 (CTMS) 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。临床试验管理系统 (CTMS) 市场的主要参与者包括 IQVIA Inc.、Medidata (Dassault SysteMes)、Oracle、Datatrak International Inc.、Clario、SimpleTrials、Calyx（原 Parexel Informatics）、RealTime Software Solutions LLC、Laboratory Corporation Of America Holdings、Veeva Systems、Wipro、Pharmaseal International Ltd。和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按解决方案类型进行的市场吸引力分析
- 按组件分類的市场吸引力分析
- 按交付模式分類的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球临床试验管理系统 (CTMS) 市场分析：按解决方案类型

按解决方案类型概述
按解决方案类型进行历史和预测资料分析
企业
地点

第 6 章：全球临床试验管理系统 (CTMS) 市场分析：按组成部分

按组件概述
按组成部分的历史和预测资料分析
软体
服务

第 7 章：全球临床试验管理系统 (CTMS) 市场分析：依交付模式

按交付模式概述
按交付模式进行历史和预测资料分析
网路和云端
内部部署

第 8 章：全球临床试验管理系统 (CTMS) 市场分析：按最终用户

最终用户概述
最终用户的历史和预测数据分析
製药和生物技术公司
医疗器材公司
CRO 及其他

第 9 章：全球临床试验管理系统 (CTMS) 市场分析：按地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：临床试验管理系统 (CTMS) 公司的竞争格局

临床试验管理系统（CTMS）市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
IQVIA Inc.

公司概况
公司收入
产品
最新动态

Medidata (Dassault SysteMes)

公司概况
公司收入
产品
最新动态

Oracle

公司概况
公司收入
产品
最新动态

Datatrak International Inc.

公司概况
公司收入
产品
最新动态

Clario

公司概况
公司收入
产品
最新动态

SimpleTrials

公司概况
公司收入
产品
最新动态

Calyx (Formerly Parexel Informatics)

公司概况
公司收入
产品
最新动态

RealTime Software Solutions LLC

公司概况
公司收入
产品
最新动态

Laboratory Corporation Of America Holdings

公司概况
公司收入
产品
最新动态

Veeva Systems

公司概况
公司收入
产品
最新动态

Wipro

公司概况
公司收入
产品
最新动态

Pharmaseal International Ltd

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11210452

The global demand for Clinical Trials Management System (CTMS) Market is presumed to reach the market size of nearly USD 8.42 Billion by 2032 from USD 2.33 Billion in 2023 with a CAGR of 15.32% under the study period 2024-2032.

Clinical trials refer to systematic studies that evaluate the efficacy, safety, and effectiveness of new drugs, treatments, medical devices, or interventions on human participants. These trials are crucial for advancing medical knowledge, developing new therapies, and assessing potential risks and benefits before treatments are made available to the public. These studies follow strict protocols and guidelines established by regulatory authorities to ensure ethical conduct, participant safety, and reliable data collection. They typically progress through phases, from small-scale studies in healthy volunteers (Phase 1) to large-scale trials in patient populations (Phase 2 and Phase 3), culminating in regulatory review and approval processes.

MARKET DYNAMICS

The propelling prevalence of chronic diseases, aging populations, and demand for personalized medicine drive the need for new therapies and treatment options evaluated through clinical trials. Pharmaceutical and biotechnology companies, academic institutions, and government agencies invest in clinical research to address unmet medical needs and enhance patient outcomes. Advancements in biotechnology, genomics, and precision medicine technologies accelerate trial design and execution, supporting targeted therapies and biomarker-driven approaches. Integration of real-world evidence (RWE) and digital health technologies such as wearables & remote monitoring devices enhance trial efficiency, data quality, and patient engagement, facilitating decentralized trial models and adaptive trial designs.

Moreover, regulatory reforms and initiatives to streamline clinical trial processes and accelerate drug approval timelines foster innovation and investment in clinical research. Collaboration between industry stakeholders, patient advocacy groups, and regulatory agencies promotes transparency, data sharing, and patient-centered trial designs, improving recruitment and retention rates. The adoption of virtual and hybrid trial models in response to the COVID-19 pandemic drives innovation in trial conduct and participant access, paving the way for more flexible and resilient clinical trial ecosystems. However, challenges such as high trial costs, recruitment and retention of diverse patient populations, and regulatory complexities across different regions may hinder clinical trial market growth.

MARKET SEGMENTATION

This section of the Clinical Trials Management System (CTMS) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Solution Type

Enterprise
Site

By Component

Software
Services

By Delivery Mode

Web & Cloud Based
On Premise

By End-user

Pharmaceutical and Biotechnology Firms
Medical Device Firms
CROs & Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trials Management System (CTMS) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trials Management System (CTMS) market include IQVIA Inc., Medidata (Dassault SysteMes), Oracle, Datatrak International Inc., Clario, SimpleTrials, Calyx (Formerly Parexel Informatics), RealTime Software Solutions LLC, Laboratory Corporation Of America Holdings, Veeva Systems, Wipro, Pharmaseal International Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Solution Type
- 3.7.2 Market Attractiveness Analysis By Component
- 3.7.3 Market Attractiveness Analysis By Delivery Mode
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY SOLUTION TYPE

5.1. Overview By Solution Type
5.2. Historical and Forecast Data Analysis By Solution Type
5.3. Enterprise Historic and Forecast Sales By Regions
5.4. Site Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY COMPONENT

6.1. Overview By Component
6.2. Historical and Forecast Data Analysis By Component
6.3. Software Historic and Forecast Sales By Regions
6.4. Services Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY DELIVERY MODE

7.1. Overview By Delivery Mode
7.2. Historical and Forecast Data Analysis By Delivery Mode
7.3. Web & Cloud Based Historic and Forecast Sales By Regions
7.4. On Premise Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data Analysis By End-user
8.3. Pharmaceutical and Biotechnology Firms Historic and Forecast Sales By Regions
8.4. Medical Device Firms Historic and Forecast Sales By Regions
8.5. CROs & Others Historic and Forecast Sales By Regions

9. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) COMPANIES

10.1. Clinical Trials Management System (CTMS) Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. IQVIA Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Medidata (Dassault SysteMes)
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Oracle
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Datatrak International Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Clario
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. SimpleTrials
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Calyx (Formerly Parexel Informatics)
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. RealTime Software Solutions LLC
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Laboratory Corporation Of America Holdings
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Veeva Systems
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Wipro
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Pharmaseal International Ltd
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Solution Type (USD MN)
Enterprise Market Sales By Geography (USD MN)
Site Market Sales By Geography (USD MN)
Analysis By Component (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Analysis By Delivery Mode (USD MN)
Web & Cloud Based Market Sales By Geography (USD MN)
On Premise Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Pharmaceutical and Biotechnology Firms Market Sales By Geography (USD MN)
Medical Device Firms Market Sales By Geography (USD MN)
CROs & Others Market Sales By Geography (USD MN)
Global Clinical Trials Management System (CTMS) Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition